UniQure Appoints Matthew Kapusta As New CFO - Quick Facts

(RTTNews) - uniQure N.V. (QURE), a biopharma company developing gene therapy, announced the appointment of Matthew Kapusta as the new chief financial officer, effective January 1, 2015. Kapusta brings to the company nearly 20 years of life science industry experience from investment banking and finance, as well as corporate development positions.

Kapusta succeeds Piers Morgan, who resigned and left the company on May 20 to pursue other interests.

Kapusta joins uniQure from AngioDynamics (ANGO), where he was senior vice president responsible for corporate development, strategic planning and national accounts. Prior to that, he served as vice president of finance at Smith & Nephew Orthopaedics.

He has also held several positions in the investment banking and equity space, including his role as managing director, Healthcare Investment Banking at Collins Stewart, and leadership positions at Wells Fargo Securities and Robertson Stephens.

The company also announced changes in Supervisory Board and US-based leadership.